These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
x
|
Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2012
|
¨
|
Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from _______ to _______
|
Virginia
|
|
54-1959284
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
Large accelerated filer
x
|
|
Accelerated filer
o
|
|
Non-accelerated filer
o
|
|
Smaller reporting company
o
|
|
|
|
|
|
Page Number
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31,
2012 |
|
December 31,
2011 |
||||
|
(dollars in thousands)
|
||||||
ASSETS
|
|
|
|
||||
Investments, available-for-sale, at estimated fair value:
|
|
|
|
||||
Fixed maturities (amortized cost of $5,125,773 in 2012 and $5,172,952 in 2011)
|
$
|
5,507,664
|
|
|
$
|
5,538,174
|
|
Equity securities (cost of $1,252,214 in 2012 and $1,156,294 in 2011)
|
2,166,841
|
|
|
1,873,927
|
|
||
Short-term investments (estimated fair value approximates cost)
|
463,694
|
|
|
541,014
|
|
||
Total Investments
|
8,138,199
|
|
|
7,953,115
|
|
||
Cash and cash equivalents
|
691,797
|
|
|
775,032
|
|
||
Receivables
|
459,978
|
|
|
350,237
|
|
||
Reinsurance recoverable on unpaid losses
|
786,736
|
|
|
791,102
|
|
||
Reinsurance recoverable on paid losses
|
45,880
|
|
|
38,208
|
|
||
Deferred policy acquisition costs
|
181,686
|
|
|
194,674
|
|
||
Prepaid reinsurance premiums
|
101,149
|
|
|
97,074
|
|
||
Goodwill and intangible assets
|
967,625
|
|
|
867,558
|
|
||
Other assets
|
486,234
|
|
|
465,103
|
|
||
Total Assets
|
$
|
11,859,284
|
|
|
$
|
11,532,103
|
|
LIABILITIES AND EQUITY
|
|
|
|
||||
Unpaid losses and loss adjustment expenses
|
$
|
5,357,151
|
|
|
$
|
5,398,869
|
|
Unearned premiums
|
975,832
|
|
|
915,930
|
|
||
Payables to insurance companies
|
127,913
|
|
|
64,327
|
|
||
Senior long-term debt and other debt (estimated fair value of $1,424,000 in 2012 and $1,391,000 in 2011)
|
1,305,573
|
|
|
1,293,520
|
|
||
Other liabilities
|
416,847
|
|
|
397,111
|
|
||
Total Liabilities
|
8,183,316
|
|
|
8,069,757
|
|
||
Commitments and contingencies
|
|
|
|
||||
Shareholders’ equity:
|
|
|
|
||||
Common stock
|
902,441
|
|
|
891,507
|
|
||
Retained earnings
|
1,890,040
|
|
|
1,835,086
|
|
||
Accumulated other comprehensive income
|
809,612
|
|
|
660,920
|
|
||
Total Shareholders’ Equity
|
3,602,093
|
|
|
3,387,513
|
|
||
Noncontrolling interests
|
73,875
|
|
|
74,833
|
|
||
Total Equity
|
3,675,968
|
|
|
3,462,346
|
|
||
Total Liabilities and Equity
|
$
|
11,859,284
|
|
|
$
|
11,532,103
|
|
|
Three Months Ended
March 31, |
||||||
|
2012
|
|
2011
|
||||
|
(dollars in thousands,
except per share data)
|
||||||
OPERATING REVENUES
|
|
|
|
||||
Earned premiums
|
$
|
529,596
|
|
|
$
|
463,111
|
|
Net investment income
|
79,794
|
|
|
70,099
|
|
||
Net realized investment gains
|
11,909
|
|
|
11,240
|
|
||
Other revenues
|
111,836
|
|
|
77,144
|
|
||
Total Operating Revenues
|
733,135
|
|
|
621,594
|
|
||
OPERATING EXPENSES
|
|
|
|
||||
Losses and loss adjustment expenses
|
288,521
|
|
|
314,328
|
|
||
Underwriting, acquisition and insurance expenses
|
238,697
|
|
|
202,350
|
|
||
Amortization of intangible assets
|
8,804
|
|
|
6,008
|
|
||
Other expenses
|
100,404
|
|
|
68,495
|
|
||
Total Operating Expenses
|
636,426
|
|
|
591,181
|
|
||
Operating Income
|
96,709
|
|
|
30,413
|
|
||
Interest expense
|
22,167
|
|
|
18,962
|
|
||
Income Before Income Taxes
|
74,542
|
|
|
11,451
|
|
||
Income tax expense
|
16,829
|
|
|
1,590
|
|
||
Net Income
|
$
|
57,713
|
|
|
$
|
9,861
|
|
Net income attributable to noncontrolling interests
|
460
|
|
|
1,589
|
|
||
Net Income to Shareholders
|
$
|
57,253
|
|
|
$
|
8,272
|
|
|
|
|
|
||||
OTHER COMPREHENSIVE INCOME
|
|
|
|
||||
Change in net unrealized gains on investments, net of taxes:
|
|
|
|
||||
Net holding gains arising during the period
|
$
|
153,455
|
|
|
$
|
20,321
|
|
Unrealized other-than-temporary impairment losses on fixed maturities arising during the period
|
(138
|
)
|
|
(176
|
)
|
||
Reclassification adjustments for net gains included in net income
|
(7,931
|
)
|
|
(6,464
|
)
|
||
Change in net unrealized gains on investments, net of taxes
|
145,386
|
|
|
13,681
|
|
||
Change in foreign currency translation adjustments, net of taxes
|
2,823
|
|
|
2,439
|
|
||
Change in net actuarial pension loss, net of taxes
|
483
|
|
|
346
|
|
||
Total Other Comprehensive Income
|
148,692
|
|
|
16,466
|
|
||
Comprehensive Income
|
$
|
206,405
|
|
|
$
|
26,327
|
|
Comprehensive income attributable to noncontrolling interests
|
460
|
|
|
1,589
|
|
||
Comprehensive Income to Shareholders
|
$
|
205,945
|
|
|
$
|
24,738
|
|
|
|
|
|
||||
NET INCOME PER SHARE
|
|
|
|
||||
Basic
|
$
|
5.94
|
|
|
$
|
0.85
|
|
Diluted
|
$
|
5.92
|
|
|
$
|
0.85
|
|
|
Common
Stock
|
|
Retained
Earnings
|
|
Accumulated
Other
Comprehensive
Income
|
|
Total
Shareholders’
Equity
|
|
Noncontrolling
Interests
|
|
Total Equity
|
||||||||||||
|
(dollars in thousands)
|
||||||||||||||||||||||
December 31, 2010
|
$
|
884,457
|
|
|
$
|
1,735,973
|
|
|
$
|
551,093
|
|
|
$
|
3,171,523
|
|
|
$
|
16,169
|
|
|
$
|
3,187,692
|
|
Net income
|
|
|
8,272
|
|
|
—
|
|
|
8,272
|
|
|
1,589
|
|
|
9,861
|
|
|||||||
Change in net unrealized gains on investments, net of taxes
|
|
|
—
|
|
|
13,681
|
|
|
13,681
|
|
|
—
|
|
|
13,681
|
|
|||||||
Change in foreign currency translation adjustments, net of taxes
|
|
|
—
|
|
|
2,439
|
|
|
2,439
|
|
|
—
|
|
|
2,439
|
|
|||||||
Change in net actuarial pension loss, net of taxes
|
|
|
—
|
|
|
346
|
|
|
346
|
|
|
—
|
|
|
346
|
|
|||||||
Comprehensive Income
|
|
|
|
|
|
|
24,738
|
|
|
1,589
|
|
|
26,327
|
|
|||||||||
Issuance of common stock
|
163
|
|
|
—
|
|
|
—
|
|
|
163
|
|
|
—
|
|
|
163
|
|
||||||
Restricted stock units expensed
|
1,902
|
|
|
—
|
|
|
—
|
|
|
1,902
|
|
|
—
|
|
|
1,902
|
|
||||||
Acquisitions
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
47,292
|
|
|
47,292
|
|
||||||
Other
|
52
|
|
|
—
|
|
|
—
|
|
|
52
|
|
|
(359
|
)
|
|
(307
|
)
|
||||||
March 31, 2011
|
$
|
886,574
|
|
|
$
|
1,744,245
|
|
|
$
|
567,559
|
|
|
$
|
3,198,378
|
|
|
$
|
64,691
|
|
|
$
|
3,263,069
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
December 31, 2011
|
$
|
891,507
|
|
|
$
|
1,835,086
|
|
|
$
|
660,920
|
|
|
$
|
3,387,513
|
|
|
$
|
74,833
|
|
|
$
|
3,462,346
|
|
Net income
|
|
|
57,253
|
|
|
—
|
|
|
57,253
|
|
|
460
|
|
|
57,713
|
|
|||||||
Change in net unrealized gains on investments, net of taxes
|
|
|
—
|
|
|
145,386
|
|
|
145,386
|
|
|
—
|
|
|
145,386
|
|
|||||||
Change in foreign currency translation adjustments, net of taxes
|
|
|
—
|
|
|
2,823
|
|
|
2,823
|
|
|
—
|
|
|
2,823
|
|
|||||||
Change in net actuarial pension loss, net of taxes
|
|
|
—
|
|
|
483
|
|
|
483
|
|
|
—
|
|
|
483
|
|
|||||||
Comprehensive Income
|
|
|
|
|
|
|
205,945
|
|
|
460
|
|
|
206,405
|
|
|||||||||
Issuance of common stock
|
8,274
|
|
|
—
|
|
|
—
|
|
|
8,274
|
|
|
—
|
|
|
8,274
|
|
||||||
Repurchase of common stock
|
—
|
|
|
(2,299
|
)
|
|
—
|
|
|
(2,299
|
)
|
|
—
|
|
|
(2,299
|
)
|
||||||
Restricted stock units expensed
|
2,366
|
|
|
—
|
|
|
—
|
|
|
2,366
|
|
|
—
|
|
|
2,366
|
|
||||||
Other
|
294
|
|
|
—
|
|
|
—
|
|
|
294
|
|
|
(1,418
|
)
|
|
(1,124
|
)
|
||||||
March 31, 2012
|
$
|
902,441
|
|
|
$
|
1,890,040
|
|
|
$
|
809,612
|
|
|
$
|
3,602,093
|
|
|
$
|
73,875
|
|
|
$
|
3,675,968
|
|
|
Three Months Ended
March 31, |
||||||
|
2012
|
|
2011
|
||||
|
(dollars in thousands)
|
||||||
OPERATING ACTIVITIES
|
|
|
|
||||
Net income
|
$
|
57,713
|
|
|
$
|
9,861
|
|
Adjustments to reconcile net income to net cash used by operating activities
|
(122,105
|
)
|
|
(19,064
|
)
|
||
Net Cash Used By Operating Activities
|
(64,392
|
)
|
|
(9,203
|
)
|
||
INVESTING ACTIVITIES
|
|
|
|
||||
Proceeds from sales of fixed maturities and equity securities
|
69,063
|
|
|
69,917
|
|
||
Proceeds from maturities, calls and prepayments of fixed maturities
|
119,291
|
|
|
112,952
|
|
||
Cost of fixed maturities and equity securities purchased
|
(205,926
|
)
|
|
(142,282
|
)
|
||
Net change in short-term investments
|
79,233
|
|
|
(107,606
|
)
|
||
Acquisitions, net of cash acquired
|
(80,870
|
)
|
|
(3,886
|
)
|
||
Additions to property and equipment
|
(12,917
|
)
|
|
(12,839
|
)
|
||
Other
|
1,476
|
|
|
(7,784
|
)
|
||
Net Cash Used By Investing Activities
|
(30,650
|
)
|
|
(91,528
|
)
|
||
FINANCING ACTIVITIES
|
|
|
|
||||
Additions to senior long-term debt and other debt
|
32,317
|
|
|
35,717
|
|
||
Repayments of senior long-term debt and other debt
|
(27,868
|
)
|
|
(33,873
|
)
|
||
Repurchases of common stock
|
(2,299
|
)
|
|
—
|
|
||
Other
|
6,953
|
|
|
(103
|
)
|
||
Net Cash Provided By Financing Activities
|
9,103
|
|
|
1,741
|
|
||
Effect of foreign currency rate changes on cash and cash equivalents
|
2,704
|
|
|
3,678
|
|
||
Decrease in cash and cash equivalents
|
(83,235
|
)
|
|
(95,312
|
)
|
||
Cash and cash equivalents at beginning of period
|
775,032
|
|
|
745,259
|
|
||
CASH AND CASH EQUIVALENTS AT END OF PERIOD
|
$
|
691,797
|
|
|
$
|
649,947
|
|
|
Three Months Ended
March 31, |
||||||
(in thousands, except per share amounts)
|
2012
|
|
2011
|
||||
Net income to shareholders
|
$
|
57,253
|
|
|
$
|
8,272
|
|
Basic common shares outstanding
|
9,642
|
|
|
9,717
|
|
||
Dilutive potential common shares
|
29
|
|
|
40
|
|
||
Diluted shares outstanding
|
9,671
|
|
|
9,757
|
|
||
Basic net income per share
|
$
|
5.94
|
|
|
$
|
0.85
|
|
Diluted net income per share
|
$
|
5.92
|
|
|
$
|
0.85
|
|
|
Three Months Ended March 31,
|
||||||||||||||
(dollars in thousands)
|
2012
|
|
2011
|
||||||||||||
|
Written
|
|
Earned
|
|
Written
|
|
Earned
|
||||||||
Direct
|
$
|
518,540
|
|
|
$
|
509,589
|
|
|
$
|
473,210
|
|
|
$
|
446,138
|
|
Assumed
|
130,078
|
|
|
83,842
|
|
|
117,573
|
|
|
81,450
|
|
||||
Ceded
|
(67,452
|
)
|
|
(63,835
|
)
|
|
(71,771
|
)
|
|
(64,477
|
)
|
||||
Net premiums
|
$
|
581,166
|
|
|
$
|
529,596
|
|
|
$
|
519,012
|
|
|
$
|
463,111
|
|
|
|
|
|
|
|
|
|
a)
|
The following tables summarize the Company’s available-for-sale investments.
|
|
March 31, 2012
|
||||||||||||||||||
(dollars in thousands)
|
Amortized
Cost
|
|
Gross
Unrealized
Holding
Gains
|
|
Gross
Unrealized
Holding
Losses
|
|
Unrealized
Other-Than-
Temporary
Impairment
Losses
|
|
Estimated
Fair
Value
|
||||||||||
Fixed maturities:
|
|
|
|
|
|
|
|
|
|
||||||||||
U.S. Treasury securities and obligations of U.S. government agencies
|
$
|
325,998
|
|
|
$
|
20,302
|
|
|
$
|
(222
|
)
|
|
$
|
—
|
|
|
$
|
346,078
|
|
Obligations of states, municipalities and political subdivisions
|
2,709,251
|
|
|
208,549
|
|
|
(924
|
)
|
|
—
|
|
|
2,916,876
|
|
|||||
Foreign governments
|
576,187
|
|
|
44,863
|
|
|
(331
|
)
|
|
—
|
|
|
620,719
|
|
|||||
Residential mortgage-backed securities
|
331,526
|
|
|
23,990
|
|
|
(5
|
)
|
|
(2,258
|
)
|
|
353,253
|
|
|||||
Asset-backed securities
|
15,779
|
|
|
688
|
|
|
—
|
|
|
—
|
|
|
16,467
|
|
|||||
Public utilities
|
65,294
|
|
|
5,536
|
|
|
—
|
|
|
—
|
|
|
70,830
|
|
|||||
All other corporate bonds
|
1,101,738
|
|
|
88,804
|
|
|
(303
|
)
|
|
(6,798
|
)
|
|
1,183,441
|
|
|||||
Total fixed maturities
|
5,125,773
|
|
|
392,732
|
|
|
(1,785
|
)
|
|
(9,056
|
)
|
|
5,507,664
|
|
|||||
Equity securities:
|
|
|
|
|
|
|
|
|
|
||||||||||
Insurance companies, banks and trusts
|
417,044
|
|
|
351,298
|
|
|
—
|
|
|
—
|
|
|
768,342
|
|
|||||
Industrial, consumer and all other
|
835,170
|
|
|
563,930
|
|
|
(601
|
)
|
|
—
|
|
|
1,398,499
|
|
|||||
Total equity securities
|
1,252,214
|
|
|
915,228
|
|
|
(601
|
)
|
|
—
|
|
|
2,166,841
|
|
|||||
Short-term investments
|
463,697
|
|
|
4
|
|
|
(7
|
)
|
|
—
|
|
|
463,694
|
|
|||||
Investments, available-for-sale
|
$
|
6,841,684
|
|
|
$
|
1,307,964
|
|
|
$
|
(2,393
|
)
|
|
$
|
(9,056
|
)
|
|
$
|
8,138,199
|
|
|
December 31, 2011
|
||||||||||||||||||
(dollars in thousands)
|
Amortized
Cost
|
|
Gross
Unrealized
Holding
Gains
|
|
Gross
Unrealized
Holding
Losses
|
|
Unrealized
Other-Than-
Temporary
Impairment
Losses
|
|
Estimated
Fair
Value
|
||||||||||
Fixed maturities:
|
|
|
|
|
|
|
|
|
|
||||||||||
U.S. Treasury securities and obligations of U.S. government agencies
|
$
|
299,413
|
|
|
$
|
22,789
|
|
|
$
|
(9
|
)
|
|
$
|
—
|
|
|
$
|
322,193
|
|
Obligations of states, municipalities and political subdivisions
|
2,729,838
|
|
|
201,477
|
|
|
(794
|
)
|
|
—
|
|
|
2,930,521
|
|
|||||
Foreign governments
|
572,253
|
|
|
45,629
|
|
|
(1,068
|
)
|
|
—
|
|
|
616,814
|
|
|||||
Residential mortgage-backed securities
|
366,859
|
|
|
24,601
|
|
|
(18
|
)
|
|
(2,258
|
)
|
|
389,184
|
|
|||||
Asset-backed securities
|
16,096
|
|
|
731
|
|
|
(9
|
)
|
|
—
|
|
|
16,818
|
|
|||||
Public utilities
|
63,965
|
|
|
5,462
|
|
|
—
|
|
|
—
|
|
|
69,427
|
|
|||||
All other corporate bonds
|
1,124,528
|
|
|
78,053
|
|
|
(2,750
|
)
|
|
(6,614
|
)
|
|
1,193,217
|
|
|||||
Total fixed maturities
|
5,172,952
|
|
|
378,742
|
|
|
(4,648
|
)
|
|
(8,872
|
)
|
|
5,538,174
|
|
|||||
Equity securities:
|
|
|
|
|
|
|
|
|
|
||||||||||
Insurance companies, banks and trusts
|
389,421
|
|
|
296,648
|
|
|
(1,366
|
)
|
|
—
|
|
|
684,703
|
|
|||||
Industrial, consumer and all other
|
766,873
|
|
|
425,131
|
|
|
(2,780
|
)
|
|
—
|
|
|
1,189,224
|
|
|||||
Total equity securities
|
1,156,294
|
|
|
721,779
|
|
|
(4,146
|
)
|
|
—
|
|
|
1,873,927
|
|
|||||
Short-term investments
|
541,014
|
|
|
4
|
|
|
(4
|
)
|
|
—
|
|
|
541,014
|
|
|||||
Investments, available-for-sale
|
$
|
6,870,260
|
|
|
$
|
1,100,525
|
|
|
$
|
(8,798
|
)
|
|
$
|
(8,872
|
)
|
|
$
|
7,953,115
|
|
b)
|
The following tables summarize gross unrealized investment losses by the length of time that securities have continuously been in an unrealized loss position.
|
|
March 31, 2012
|
||||||||||||||||||||||
|
Less than 12 months
|
|
12 months or longer
|
|
Total
|
||||||||||||||||||
(dollars in thousands)
|
Estimated
Fair
Value
|
|
Gross
Unrealized
Holding and
Other-Than-
Temporary
Impairment
Losses
|
|
Estimated
Fair
Value
|
|
Gross
Unrealized
Holding and
Other-Than-
Temporary
Impairment
Losses
|
|
Estimated
Fair
Value
|
|
Gross
Unrealized
Holding and
Other-Than-
Temporary
Impairment
Losses
|
||||||||||||
Fixed maturities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
U.S. Treasury securities and obligations of U.S. government agencies
|
$
|
78,023
|
|
|
$
|
(222
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
78,023
|
|
|
$
|
(222
|
)
|
Obligations of states, municipalities and political subdivisions
|
12,592
|
|
|
(240
|
)
|
|
16,189
|
|
|
(684
|
)
|
|
28,781
|
|
|
(924
|
)
|
||||||
Foreign governments
|
35,520
|
|
|
(331
|
)
|
|
—
|
|
|
—
|
|
|
35,520
|
|
|
(331
|
)
|
||||||
Residential mortgage-backed securities
|
551
|
|
|
(2,263
|
)
|
|
—
|
|
|
—
|
|
|
551
|
|
|
(2,263
|
)
|
||||||
Asset-backed securities
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
All other corporate bonds
|
15,137
|
|
|
(6,954
|
)
|
|
5,908
|
|
|
(147
|
)
|
|
21,045
|
|
|
(7,101
|
)
|
||||||
Total fixed maturities
|
141,823
|
|
|
(10,010
|
)
|
|
22,097
|
|
|
(831
|
)
|
|
163,920
|
|
|
(10,841
|
)
|
||||||
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Insurance companies, banks and trusts
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Industrial, consumer and all other
|
32,272
|
|
|
(590
|
)
|
|
99
|
|
|
(11
|
)
|
|
32,371
|
|
|
(601
|
)
|
||||||
Total equity securities
|
32,272
|
|
|
(590
|
)
|
|
99
|
|
|
(11
|
)
|
|
32,371
|
|
|
(601
|
)
|
||||||
Short-term investments
|
46,995
|
|
|
(7
|
)
|
|
—
|
|
|
—
|
|
|
46,995
|
|
|
(7
|
)
|
||||||
Total
|
$
|
221,090
|
|
|
$
|
(10,607
|
)
|
|
$
|
22,196
|
|
|
$
|
(842
|
)
|
|
$
|
243,286
|
|
|
$
|
(11,449
|
)
|
|
December 31, 2011
|
||||||||||||||||||||||
|
Less than 12 months
|
|
12 months or longer
|
|
Total
|
||||||||||||||||||
(dollars in thousands)
|
Estimated
Fair
Value
|
|
Gross
Unrealized
Holding and
Other-Than-
Temporary
Impairment
Losses
|
|
Estimated
Fair
Value
|
|
Gross
Unrealized
Holding and
Other-Than-
Temporary
Impairment
Losses
|
|
Estimated
Fair
Value
|
|
Gross
Unrealized
Holding and
Other-Than-
Temporary
Impairment
Losses
|
||||||||||||
Fixed maturities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
U.S. Treasury securities and obligations of U.S. government agencies
|
$
|
32,384
|
|
|
$
|
(9
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
32,384
|
|
|
$
|
(9
|
)
|
Obligations of states, municipalities and political subdivisions
|
1,016
|
|
|
(2
|
)
|
|
17,261
|
|
|
(792
|
)
|
|
18,277
|
|
|
(794
|
)
|
||||||
Foreign governments
|
40,340
|
|
|
(1,068
|
)
|
|
—
|
|
|
—
|
|
|
40,340
|
|
|
(1,068
|
)
|
||||||
Residential mortgage-backed securities
|
489
|
|
|
(2,263
|
)
|
|
2,045
|
|
|
(13
|
)
|
|
2,534
|
|
|
(2,276
|
)
|
||||||
Asset-backed securities
|
—
|
|
|
—
|
|
|
32
|
|
|
(9
|
)
|
|
32
|
|
|
(9
|
)
|
||||||
All other corporate bonds
|
74,812
|
|
|
(7,829
|
)
|
|
7,923
|
|
|
(1,535
|
)
|
|
82,735
|
|
|
(9,364
|
)
|
||||||
Total fixed maturities
|
149,041
|
|
|
(11,171
|
)
|
|
27,261
|
|
|
(2,349
|
)
|
|
176,302
|
|
|
(13,520
|
)
|
||||||
Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Insurance companies, banks and trusts
|
26,514
|
|
|
(1,366
|
)
|
|
—
|
|
|
—
|
|
|
26,514
|
|
|
(1,366
|
)
|
||||||
Industrial, consumer and all other
|
70,555
|
|
|
(2,774
|
)
|
|
18,525
|
|
|
(6
|
)
|
|
89,080
|
|
|
(2,780
|
)
|
||||||
Total equity securities
|
97,069
|
|
|
(4,140
|
)
|
|
18,525
|
|
|
(6
|
)
|
|
115,594
|
|
|
(4,146
|
)
|
||||||
Short-term investments
|
295,991
|
|
|
(4
|
)
|
|
—
|
|
|
—
|
|
|
295,991
|
|
|
(4
|
)
|
||||||
Total
|
$
|
542,101
|
|
|
$
|
(15,315
|
)
|
|
$
|
45,786
|
|
|
$
|
(2,355
|
)
|
|
$
|
587,887
|
|
|
$
|
(17,670
|
)
|
•
|
fundamentals of the issuer, including current and projected earnings, current liquidity position and ability to raise capital;
|
•
|
fundamentals of the industry in which the issuer operates;
|
•
|
expectations of defaults and recovery rates;
|
•
|
changes in ratings by rating agencies;
|
•
|
other relevant market considerations; and
|
•
|
receipt of interest payments
|
c)
|
The amortized cost and estimated fair value of fixed maturities at
March 31, 2012
are shown below by contractual maturity.
|
(dollars in thousands)
|
Amortized
Cost
|
|
Estimated
Fair Value
|
||||
Due in one year or less
|
$
|
296,224
|
|
|
$
|
301,089
|
|
Due after one year through five years
|
1,356,224
|
|
|
1,460,975
|
|
||
Due after five years through ten years
|
1,601,045
|
|
|
1,730,807
|
|
||
Due after ten years
|
1,524,975
|
|
|
1,645,073
|
|
||
|
4,778,468
|
|
|
5,137,944
|
|
||
Residential mortgage-backed securities
|
331,526
|
|
|
353,253
|
|
||
Asset-backed securities
|
15,779
|
|
|
16,467
|
|
||
Total fixed maturities
|
$
|
5,125,773
|
|
|
$
|
5,507,664
|
|
d)
|
At
March 31, 2012
and
2011
, cumulative credit losses recognized in net income on fixed maturities where other-than-temporary impairment was identified and a portion of the other-than-temporary impairment was included in other comprehensive income were
$21,370
and
$10,307
, respectively. There were no changes in cumulative credit losses for the three months ended
March 31, 2012
or
2011
.
|
|
|
|
|
|
|
|
|
e)
|
The following table presents net realized investment gains and the change in net unrealized gains on investments.
|
|
Three Months Ended March 31,
|
||||||
(dollars in thousands)
|
2012
|
|
2011
|
||||
Realized gains:
|
|
|
|
||||
Sales of fixed maturities
|
$
|
1,859
|
|
|
$
|
7,988
|
|
Sales of equity securities
|
9,694
|
|
|
2,071
|
|
||
Other
|
521
|
|
|
1,425
|
|
||
Total realized gains
|
12,074
|
|
|
11,484
|
|
||
Realized losses:
|
|
|
|
||||
Sales of fixed maturities
|
(165
|
)
|
|
(244
|
)
|
||
Other-than-temporary impairments
|
—
|
|
|
—
|
|
||
Other
|
—
|
|
|
—
|
|
||
Total realized losses
|
(165
|
)
|
|
(244
|
)
|
||
Net realized investment gains
|
$
|
11,909
|
|
|
$
|
11,240
|
|
Change in net unrealized gains on investments:
|
|
|
|
||||
Fixed maturities
|
$
|
16,669
|
|
|
$
|
(16,396
|
)
|
Equity securities
|
196,994
|
|
|
36,857
|
|
||
Short-term investments
|
(3
|
)
|
|
3
|
|
||
Net increase
|
$
|
213,660
|
|
|
$
|
20,464
|
|
|
|
|
|
f)
|
There were no writedowns for other-than-temporary declines in the estimated fair value of investments for the three months ended
March 31, 2012
and
2011
.
|
|
|
|
|
|
|
|
|
a)
|
The following tables summarize the Company’s segment disclosures.
|
Three Months Ended March 31, 2012
|
|||||||||||||||||||||||
(dollars in thousands)
|
Excess and
Surplus
Lines
|
|
Specialty
Admitted
|
|
London
Insurance
Market
|
|
Other
Insurance
(Discontinued
Lines)
|
|
Investing
|
|
Consolidated
|
||||||||||||
Gross premium volume
|
$
|
222,929
|
|
|
$
|
148,122
|
|
|
$
|
277,566
|
|
|
$
|
1
|
|
|
$
|
—
|
|
|
$
|
648,618
|
|
Net written premiums
|
192,913
|
|
|
140,552
|
|
|
247,700
|
|
|
1
|
|
|
—
|
|
|
581,166
|
|
||||||
Earned premiums
|
199,378
|
|
|
133,475
|
|
|
196,742
|
|
|
1
|
|
|
—
|
|
|
529,596
|
|
||||||
Losses and loss adjustment expenses:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Current accident year
|
(128,067
|
)
|
|
(92,693
|
)
|
|
(131,746
|
)
|
|
—
|
|
|
—
|
|
|
(352,506
|
)
|
||||||
Prior accident years
|
30,587
|
|
|
4,326
|
|
|
21,465
|
|
|
7,607
|
|
|
—
|
|
|
63,985
|
|
||||||
Underwriting, acquisition and insurance expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Prospective adoption of ASU 2010-26
(1)
|
(8,487
|
)
|
|
(5,764
|
)
|
|
(6,037
|
)
|
|
—
|
|
|
—
|
|
|
(20,288
|
)
|
||||||
All other expenses
|
(85,857
|
)
|
|
(57,266
|
)
|
|
(75,003
|
)
|
|
(283
|
)
|
|
—
|
|
|
(218,409
|
)
|
||||||
Underwriting profit (loss)
|
7,554
|
|
|
(17,922
|
)
|
|
5,421
|
|
|
7,325
|
|
|
—
|
|
|
2,378
|
|
||||||
Net investment income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
79,794
|
|
|
79,794
|
|
||||||
Net realized investment gains
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11,909
|
|
|
11,909
|
|
||||||
Other revenues (insurance)
|
—
|
|
|
10,448
|
|
|
4,383
|
|
|
—
|
|
|
—
|
|
|
14,831
|
|
||||||
Other expenses (insurance)
|
—
|
|
|
(11,201
|
)
|
|
(974
|
)
|
|
—
|
|
|
—
|
|
|
(12,175
|
)
|
||||||
Segment profit (loss)
|
$
|
7,554
|
|
|
$
|
(18,675
|
)
|
|
$
|
8,830
|
|
|
$
|
7,325
|
|
|
$
|
91,703
|
|
|
$
|
96,737
|
|
Other revenues (non-insurance)
|
|
|
|
|
|
|
|
|
|
|
97,005
|
|
|||||||||||
Other expenses (non-insurance)
|
|
|
|
|
|
|
|
|
|
|
(88,229
|
)
|
|||||||||||
Amortization of intangible assets
|
|
|
|
|
|
|
|
|
|
|
(8,804
|
)
|
|||||||||||
Interest expense
|
|
|
|
|
|
|
|
|
|
|
(22,167
|
)
|
|||||||||||
Income before income taxes
|
|
|
|
|
|
|
|
|
|
|
$
|
74,542
|
|
||||||||||
U.S. GAAP combined ratio
(2)
|
96
|
%
|
|
113
|
%
|
|
97
|
%
|
|
NM
|
|
(3)
|
|
|
100
|
%
|
Three Months Ended March 31, 2011
|
|||||||||||||||||||||||
(dollars in thousands)
|
Excess and
Surplus
Lines
|
|
Specialty
Admitted
|
|
London
Insurance
Market
|
|
Other
Insurance
(Discontinued
Lines)
|
|
Investing
|
|
Consolidated
|
||||||||||||
Gross premium volume
|
$
|
201,371
|
|
|
$
|
134,321
|
|
|
$
|
255,001
|
|
|
$
|
90
|
|
|
$
|
—
|
|
|
$
|
590,783
|
|
Net written premiums
|
175,537
|
|
|
127,239
|
|
|
216,139
|
|
|
97
|
|
|
—
|
|
|
519,012
|
|
||||||
Earned premiums
|
181,057
|
|
|
122,476
|
|
|
159,483
|
|
|
95
|
|
|
—
|
|
|
463,111
|
|
||||||
Losses and loss adjustment expenses:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Current accident year
|
(122,507
|
)
|
|
(78,470
|
)
|
|
(187,876
|
)
|
|
—
|
|
|
—
|
|
|
(388,853
|
)
|
||||||
Prior accident years
|
56,792
|
|
|
198
|
|
|
12,634
|
|
|
4,901
|
|
|
—
|
|
|
74,525
|
|
||||||
Underwriting, acquisition and insurance expenses
|
(85,920
|
)
|
|
(49,473
|
)
|
|
(66,725
|
)
|
|
(232
|
)
|
|
—
|
|
|
(202,350
|
)
|
||||||
Underwriting profit (loss)
|
29,422
|
|
|
(5,269
|
)
|
|
(82,484
|
)
|
|
4,764
|
|
|
—
|
|
|
(53,567
|
)
|
||||||
Net investment income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
70,099
|
|
|
70,099
|
|
||||||
Net realized investment gains
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11,240
|
|
|
11,240
|
|
||||||
Other revenues (insurance)
|
—
|
|
|
9,186
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
9,186
|
|
||||||
Other expenses (insurance)
|
—
|
|
|
(11,740
|
)
|
|
(8
|
)
|
|
—
|
|
|
—
|
|
|
(11,748
|
)
|
||||||
Segment profit (loss)
|
$
|
29,422
|
|
|
$
|
(7,823
|
)
|
|
$
|
(82,492
|
)
|
|
$
|
4,764
|
|
|
$
|
81,339
|
|
|
$
|
25,210
|
|
Other revenues (non-insurance)
|
|
|
|
|
|
|
|
|
|
|
67,958
|
|
|||||||||||
Other expenses (non-insurance)
|
|
|
|
|
|
|
|
|
|
|
(56,747
|
)
|
|||||||||||
Amortization of intangible assets
|
|
|
|
|
|
|
|
|
|
|
(6,008
|
)
|
|||||||||||
Interest expense
|
|
|
|
|
|
|
|
|
|
|
(18,962
|
)
|
|||||||||||
Income before income taxes
|
|
|
|
|
|
|
|
|
|
|
$
|
11,451
|
|
||||||||||
U.S. GAAP combined ratio
(2)
|
84
|
%
|
|
104
|
%
|
|
152
|
%
|
|
NM
|
|
(3)
|
|
|
112
|
%
|
(1)
|
Effective January 1, 2012, the Company prospectively adopted Financial Accounting Standards Board (FASB) Accounting Standards Update (ASU) No. 2010-26,
Accounting for Costs Associated with Acquiring or Renewing Insurance Contracts
. At December 31, 2011, deferred policy acquisition costs included approximately
$43 million
of costs that no longer met the criteria for deferral as of January 1, 2012 and will be recognized into income primarily over the first nine months of 2012, consistent with policy terms. The three months ended March 31, 2012 included
$20.3 million
of underwriting, acquisition and insurance expenses that were deferred as of December 31, 2011 and no longer met the criteria for deferral as of January 1, 2012.
|
(2)
|
The U.S. GAAP combined ratio is a measure of underwriting performance and represents the relationship of incurred losses, loss adjustment expenses and underwriting, acquisition and insurance expenses to earned premiums.
|
(3)
|
NM – Ratio is not meaningful.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
b)
|
The following table reconciles segment assets to the Company’s consolidated balance sheets.
|
(dollars in thousands)
|
March 31,
2012 |
|
December 31,
2011 |
||||
Segment Assets:
|
|
|
|
||||
Investing
|
$
|
8,795,416
|
|
|
$
|
8,692,391
|
|
Underwriting
|
2,427,176
|
|
|
2,209,431
|
|
||
Total Segment Assets
|
$
|
11,222,592
|
|
|
$
|
10,901,822
|
|
Non-insurance operations
|
636,692
|
|
|
630,281
|
|
||
Total Assets
|
$
|
11,859,284
|
|
|
$
|
11,532,103
|
|
a)
|
Expenses relating to the Company’s defined contribution plans were
$4.7 million
and
$4.4 million
for the three months ended
March 31, 2012
and
2011
, respectively.
|
b)
|
The following table presents the components of net periodic benefit cost (income) for the Terra Nova Pension Plan, a defined benefit plan.
|
|
Three Months Ended
March 31, |
||||||
(dollars in thousands)
|
2012
|
|
2011
|
||||
Service cost
|
$
|
90
|
|
|
$
|
337
|
|
Interest cost
|
1,693
|
|
|
1,768
|
|
||
Expected return on plan assets
|
(2,432
|
)
|
|
(2,443
|
)
|
||
Amortization of net actuarial pension loss
|
643
|
|
|
474
|
|
||
Net periodic benefit cost (income)
|
$
|
(6
|
)
|
|
$
|
136
|
|
|
March 31, 2012
|
||||||||||||||
(dollars in thousands)
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
Assets:
|
|
|
|
|
|
|
|
||||||||
Investments available-for-sale:
|
|
|
|
|
|
|
|
||||||||
Fixed maturities:
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury securities and obligations of U.S. government agencies
|
$
|
—
|
|
|
$
|
346,078
|
|
|
$
|
—
|
|
|
$
|
346,078
|
|
Obligations of states, municipalities and political subdivisions
|
—
|
|
|
2,916,876
|
|
|
—
|
|
|
2,916,876
|
|
||||
Foreign governments
|
—
|
|
|
620,719
|
|
|
—
|
|
|
620,719
|
|
||||
Residential mortgage-backed securities
|
—
|
|
|
353,253
|
|
|
—
|
|
|
353,253
|
|
||||
Asset-backed securities
|
—
|
|
|
16,467
|
|
|
—
|
|
|
16,467
|
|
||||
Public utilities
|
—
|
|
|
70,830
|
|
|
—
|
|
|
70,830
|
|
||||
All other corporate bonds
|
—
|
|
|
1,183,441
|
|
|
—
|
|
|
1,183,441
|
|
||||
Total fixed maturities
|
—
|
|
|
5,507,664
|
|
|
—
|
|
|
5,507,664
|
|
||||
Equity securities:
|
|
|
|
|
|
|
|
||||||||
Insurance companies, banks and trusts
|
768,342
|
|
|
—
|
|
|
—
|
|
|
768,342
|
|
||||
Industrial, consumer and all other
|
1,398,499
|
|
|
—
|
|
|
—
|
|
|
1,398,499
|
|
||||
Total equity securities
|
2,166,841
|
|
|
—
|
|
|
—
|
|
|
2,166,841
|
|
||||
Short-term investments
|
401,162
|
|
|
62,532
|
|
|
—
|
|
|
463,694
|
|
||||
Total investments available-for-sale
|
2,568,003
|
|
|
5,570,196
|
|
|
—
|
|
|
8,138,199
|
|
||||
Liabilities:
|
|
|
|
|
|
|
|
||||||||
Derivative contracts
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
18,270
|
|
|
$
|
18,270
|
|
|
December 31, 2011
|
||||||||||||||
(dollars in thousands)
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
Assets:
|
|
|
|
|
|
|
|
||||||||
Investments available-for-sale:
|
|
|
|
|
|
|
|
||||||||
Fixed maturities:
|
|
|
|
|
|
|
|
||||||||
U.S. Treasury securities and obligations of U.S. government agencies
|
$
|
—
|
|
|
$
|
322,193
|
|
|
$
|
—
|
|
|
$
|
322,193
|
|
Obligations of states, municipalities and political subdivisions
|
—
|
|
|
2,930,521
|
|
|
—
|
|
|
2,930,521
|
|
||||
Foreign governments
|
—
|
|
|
616,814
|
|
|
—
|
|
|
616,814
|
|
||||
Residential mortgage-backed securities
|
—
|
|
|
389,184
|
|
|
—
|
|
|
389,184
|
|
||||
Asset-backed securities
|
—
|
|
|
16,818
|
|
|
—
|
|
|
16,818
|
|
||||
Public utilities
|
—
|
|
|
69,427
|
|
|
—
|
|
|
69,427
|
|
||||
All other corporate bonds
|
—
|
|
|
1,193,217
|
|
|
—
|
|
|
1,193,217
|
|
||||
Total fixed maturities
|
—
|
|
|
5,538,174
|
|
|
—
|
|
|
5,538,174
|
|
||||
Equity securities:
|
|
|
|
|
|
|
|
||||||||
Insurance companies, banks and trusts
|
684,703
|
|
|
—
|
|
|
—
|
|
|
684,703
|
|
||||
Industrial, consumer and all other
|
1,189,224
|
|
|
—
|
|
|
—
|
|
|
1,189,224
|
|
||||
Total equity securities
|
1,873,927
|
|
|
—
|
|
|
—
|
|
|
1,873,927
|
|
||||
Short-term investments
|
477,348
|
|
|
63,666
|
|
|
—
|
|
|
541,014
|
|
||||
Total investments available-for-sale
|
2,351,275
|
|
|
5,601,840
|
|
|
—
|
|
|
7,953,115
|
|
||||
Liabilities:
|
|
|
|
|
|
|
|
||||||||
Derivative contracts
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
29,331
|
|
|
$
|
29,331
|
|
|
Three Months Ended March 31,
|
|
||||||
(dollars in thousands)
|
2012
|
|
2011
|
|
||||
Derivatives, Beginning of Period
|
$
|
29,331
|
|
|
$
|
25,228
|
|
|
Total gains included in:
|
|
|
|
|
||||
Net income
|
(11,061
|
)
|
|
(1,661
|
)
|
|
||
Other comprehensive income
|
—
|
|
|
—
|
|
|
||
Transfers into Level 3
|
—
|
|
|
—
|
|
|
||
Transfers out of Level 3
|
—
|
|
|
—
|
|
|
||
Derivatives, End of Period
|
$
|
18,270
|
|
|
$
|
23,567
|
|
|
Net unrealized gains included in net income relating to liabilities held at March 31, 2012 and 2011
|
$
|
11,061
|
|
(1)
|
$
|
1,661
|
|
(1)
|
(1)
|
Included in net investment income in the consolidated statements of income and comprehensive income.
|
|
|
|
|
|
|
Three Months Ended
March 31,
|
|
|||||
(dollars in thousands)
|
2012
|
|
2011
|
||||
Underwriting profit (loss)
|
$
|
2,378
|
|
|
$
|
(53,567
|
)
|
Net investment income
|
79,794
|
|
|
70,099
|
|
||
Net realized investment gains
|
11,909
|
|
|
11,240
|
|
||
Other revenues
|
111,836
|
|
|
77,144
|
|
||
Amortization of intangible assets
|
(8,804
|
)
|
|
(6,008
|
)
|
||
Other expenses
|
(100,404
|
)
|
|
(68,495
|
)
|
||
Interest expense
|
(22,167
|
)
|
|
(18,962
|
)
|
||
Income tax expense
|
(16,829
|
)
|
|
(1,590
|
)
|
||
Net income attributable to noncontrolling interests
|
(460
|
)
|
|
(1,589
|
)
|
||
Net income to shareholders
|
$
|
57,253
|
|
|
$
|
8,272
|
|
|
Three Months Ended
March 31,
|
|
|
|||||
(dollars in thousands)
|
2012
|
|
2011
|
|
||||
Gross premium volume
|
$
|
648,618
|
|
|
$
|
590,783
|
|
|
Net written premiums
|
$
|
581,166
|
|
|
$
|
519,012
|
|
|
Net retention
|
90
|
%
|
|
88
|
%
|
|
||
Earned premiums
|
$
|
529,596
|
|
|
$
|
463,111
|
|
|
Losses and loss adjustment expenses
|
$
|
288,521
|
|
|
$
|
314,328
|
|
|
Underwriting, acquisition and insurance expenses
(1)
|
$
|
238,697
|
|
|
$
|
202,350
|
|
|
Underwriting profit (loss)
|
$
|
2,378
|
|
|
$
|
(53,567
|
)
|
|
U.S. GAAP Combined Ratios
(2)
|
|
|
|
|
||||
Excess and Surplus Lines
|
96
|
%
|
|
84
|
%
|
|
||
Specialty Admitted
|
113
|
%
|
|
104
|
%
|
|
||
London Insurance Market
|
97
|
%
|
|
152
|
%
|
|
||
Other Insurance (Discontinued Lines)
|
NM
|
|
(3)
|
NM
|
|
(3)
|
||
Markel Corporation (Consolidated)
|
100
|
%
|
|
112
|
%
|
|
(1)
|
Effective January 1, 2012, we prospectively adopted Financial Accounting Standards Board Accounting Standards Update (ASU) No. 2010-26,
Accounting for Costs Associated with Acquiring or Renewing Insurance Contracts
. At December 31, 2011, deferred acquisition costs included approximately
$43 million
of costs that no longer met the criteria for deferral as of January 1, 2012. Pursuant to the new guidance, these costs will be amortized primarily over the first nine months of 2012, consistent with policy terms. As a result of the prospective adoption of ASU No. 2010-26, underwriting, acquisition and insurance expenses for the first quarter of 2012 included
$20.3 million
of costs that were deferred as of December 31, 2011 and no longer met the criteria for deferral.
|
(2)
|
The U.S. GAAP combined ratio is a measure of underwriting performance and represents the relationship of incurred losses, loss adjustment expenses and underwriting, acquisition and insurance expenses to earned premiums. A combined ratio less than 100% indicates an underwriting profit, while a combined ratio greater than 100% reflects an underwriting loss.
|
(3)
|
NM – Ratio is not meaningful.
|
Gross Premium Volume
|
|
|
|
Net Written Premiums
|
||||||||||||
Three Months Ended March 31,
|
|
|
|
Three Months Ended March 31,
|
||||||||||||
2012
|
|
2011
|
|
(dollars in thousands)
|
|
2012
|
|
2011
|
||||||||
$
|
222,929
|
|
|
$
|
201,371
|
|
|
Excess and Surplus Lines
|
|
$
|
192,913
|
|
|
$
|
175,537
|
|
148,122
|
|
|
134,321
|
|
|
Specialty Admitted
|
|
140,552
|
|
|
127,239
|
|
||||
277,566
|
|
|
255,001
|
|
|
London Insurance Market
|
|
247,700
|
|
|
216,139
|
|
||||
1
|
|
|
90
|
|
|
Other Insurance (Discontinued Lines)
|
|
1
|
|
|
97
|
|
||||
$
|
648,618
|
|
|
$
|
590,783
|
|
|
Total
|
|
$
|
581,166
|
|
|
$
|
519,012
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31,
|
||||||
(dollars in thousands)
|
|
2012
|
|
2011
|
||||
Excess and Surplus Lines
|
|
$
|
199,378
|
|
|
$
|
181,057
|
|
Specialty Admitted
|
|
133,475
|
|
|
122,476
|
|
||
London Insurance Market
|
|
196,742
|
|
|
159,483
|
|
||
Other Insurance (Discontinued Lines)
|
|
1
|
|
|
95
|
|
||
Total
|
|
$
|
529,596
|
|
|
$
|
463,111
|
|
•
|
our anticipated premium volume is based on current knowledge and assumes no significant man-made or natural catastrophes, no significant changes in products or personnel and no adverse changes in market conditions;
|
•
|
we offer insurance coverage against terrorist acts in connection with some of our programs, and in other instances we are legally required to offer terrorism insurance; in both circumstances, we actively manage our exposure, but if there is a covered terrorist attack, we could sustain material losses;
|
•
|
the impact of the events of September 11, 2001 will depend on the resolution of on-going insurance coverage litigation and arbitrations;
|
•
|
the frequency and severity of catastrophic events (including earthquakes and weather-related catastrophes) is unpredictable and, in the case of weather-related catastrophes, may be exacerbated if, as many forecast, conditions in the oceans and atmosphere result in increased hurricane or other adverse weather-related activity;
|
•
|
changing legal and social trends and inherent uncertainties (including but not limited to those uncertainties associated with our asbestos and environmental reserves) in the loss estimation process can adversely impact the adequacy of loss reserves and the allowance for reinsurance recoverables;
|
•
|
adverse developments in insurance coverage litigation or other legal or administrative proceedings could result in material increases in our estimates of loss reserves;
|
•
|
the loss estimation process may become more uncertain if we experience a period of rising inflation;
|
•
|
the costs and availability of reinsurance may impact our ability to write certain lines of business;
|
•
|
industry and economic conditions can affect the ability and/or willingness of reinsurers to pay balances due;
|
•
|
after the commutation of ceded reinsurance contracts, any subsequent adverse development in the re-assumed loss reserves will result in a charge to earnings;
|
•
|
regulatory actions can impede our ability to charge adequate rates and efficiently allocate capital;
|
•
|
economic conditions, actual or potential defaults in sovereign debt obligations, volatility in interest and foreign currency exchange rates and changes in market value of concentrated investments can have a significant impact on the fair value of fixed maturities and equity securities, as well as the carrying value of other assets and liabilities, and this impact may be heightened by market volatility;
|
•
|
economic conditions, changes in government support for education, healthcare and infrastructure projects and foreign currency exchange rates, among other factors, may adversely affect the markets served by our non-insurance operations and negatively impact their revenues and profitability;
|
•
|
we have substantial investments in municipal bonds (approximately
$2.9 billion
at
March 31, 2012
) and, although no more than 10% of our municipal bond portfolio is tied to any one state, widespread defaults could adversely affect our results of operations and financial condition;
|
•
|
we cannot predict the extent and duration of the current economic slowdown; the effects of government actions to address the U.S. federal deficit and debt ceiling issues; the continuing effects of government intervention into the markets to address the financial crisis of 2008 and 2009 (including, among other things, the effects of the Dodd-Frank Wall Street Reform and Consumer Protection Act and regulations adopted thereunder); the outcome of economic and currency concerns in the Eurozone; and their combined impact on our industry, business and investment portfolio;
|
•
|
we cannot predict the impact of U.S. health care reform legislation and regulations under that legislation on our business;
|
•
|
our business is dependent upon the successful functioning and security of our computer systems; if our information technology systems fail or suffer a security breach, our business or reputation could be adversely impacted;
|
•
|
we have recently completed a number of acquisitions and may engage in additional acquisition activity in the future, which
|
•
|
loss of services of any executive officers could impact our operations; and
|
•
|
adverse changes in our assigned financial strength or debt ratings could impact our ability to attract and retain business or obtain capital.
|
|
(a)
|
|
(b)
|
|
(c)
|
|
(d)
|
||||||
Period
|
Total
Number of
Shares
Purchased
|
|
Average
Price
Paid per
Share
|
|
Total
Number of
Shares
Purchased as
Part
of Publicly
Announced
Plans
or Programs
1
|
|
Approximate
Dollar
Value of
Shares that
May Yet Be
Purchased
Under
the Plans or
Programs
(in thousands)
|
||||||
January 1, 2012 through January 31, 2012
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
155,419
|
|
|
February 1, 2012 through February 29, 2012
|
3,296
|
|
|
$
|
405.67
|
|
|
3,296
|
|
|
$
|
154,082
|
|
March 1, 2012 through March 31, 2012
|
1,990
|
|
|
$
|
405.57
|
|
|
1,990
|
|
|
$
|
153,275
|
|
Total
|
5,286
|
|
|
$
|
405.63
|
|
|
5,286
|
|
|
$
|
153,275
|
|
1
|
The Board of Directors approved the repurchase of up to $200 million of our common stock pursuant to a share repurchase program publicly announced on December 1, 2010 (the Program). Under the Program, we may repurchase outstanding shares of our common stock from time to time, primarily through open-market transactions. The Program has no expiration date but may be terminated by the Board of Directors at any time.
|
|
Markel Corporation
|
||
|
|
|
|
|
By
|
|
/s/ Alan I. Kirshner
|
|
|
|
Alan I. Kirshner
|
|
|
|
Chief Executive Officer and Chairman
of the Board of Directors
|
|
|
|
|
|
By
|
|
/s/ Anne G. Waleski
|
|
|
|
Anne G. Waleski
|
|
|
|
Vice President and Chief Financial Officer
(Principal Financial Officer)
|
Number
|
|
Description
|
|
|
|
3(i)
|
|
Amended and Restated Articles of Incorporation (3.1)a
|
|
|
|
3(ii)
|
|
Bylaws, as amended (3.1)b
|
|
|
|
4.1
|
|
Form of Amended and Restated Credit Agreement dated as of September 23, 2011 among Markel Corporation, the lenders party thereto and SunTrust Bank, as Administrative Agent (4.1)c
|
|
|
|
4.2
|
|
Indenture dated as of June 5, 2001, between Markel Corporation and The Chase Manhattan Bank, as Trustee (4.1)d
|
|
|
|
4.3
|
|
Form of Second Supplemental Indenture dated as of February 25, 2003 between Markel Corporation and JPMorgan Chase Bank (formerly known as The Chase Manhattan Bank), as Trustee, including form of the securities as Exhibit A (4.1)e
|
|
|
|
4.4
|
|
Form of Third Supplemental Indenture dated as of August 13, 2004 between Markel Corporation and JPMorgan Chase Bank (formerly known as The Chase Manhattan Bank), as Trustee, including form of the securities as Exhibit A (4.2)f
|
|
|
|
4.5
|
|
Form of Fourth Supplemental Indenture dated as of August 22, 2006 between Markel Corporation and J.P. Morgan Trust Company, National Association (as successor to The Chase Manhattan Bank), as Trustee, including form of the securities as Exhibit A (4.2)g
|
|
|
|
4.6
|
|
Form of Fifth Supplemental Indenture dated as of September 22, 2009 between Markel Corporation and The Bank of New York Mellon (as successor to The Chase Manhattan Bank), as Trustee, including form of the securities as Exhibit A (4.2)h
|
|
|
|
4.7
|
|
Form of Sixth Supplemental Indenture dated as of June 1, 2011 between Markel Corporation and The Bank of New York Mellon (as successor to The Chase Manhattan Bank), as Trustee, including form of the securities as Exhibit A (4.2)i
The registrant hereby agrees to furnish to the Securities and Exchange Commission a copy of all instruments defining the rights of holders of long-term debt of the registrant’s subsidiaries shown on the Consolidated Balance Sheet of the registrant at March 31, 2012 and the respective Notes thereto, included in this Quarterly Report on Form 10-Q.
|
|
|
|
10.1
|
|
Description of Awards under Executive Bonus Plan and Omnibus Incentive Plan for 2012*
|
|
|
|
10.2
|
|
Schedule of Base Annual Salaries for Executive Officers*
|
|
|
|
31.1
|
|
Certification of Principal Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a)*
|
|
|
|
31.2
|
|
Certification of Principal Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a)*
|
|
|
|
32.1
|
|
Certification of Principal Executive Officer furnished Pursuant to 18 U.S.C. Section 1350*
|
|
|
|
32.2
|
|
Certification of Principal Financial Officer furnished Pursuant to 18 U.S.C. Section 1350*
|
|
|
|
101
|
|
The following consolidated financial statements from Markel Corporation’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2012, filed on May 9, 2012, formatted in XBRL: (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Income and Comprehensive Income, (iii) Consolidated Statements of Changes in Equity, (iv) Consolidated Statements of Cash Flows and (v) Notes to Consolidated Financial Statements.*
|
a.
|
Incorporated by reference from the Exhibit shown in parentheses filed with the Commission in the Registrant’s report on Form 8-K filed on May 13, 2011.
|
b.
|
Incorporated by reference from the Exhibit shown in parentheses filed with the Commission in the Registrant’s report on Form 8-K filed on November 18, 2011.
|
c.
|
Incorporated by reference from the Exhibit shown in parentheses filed with the Commission in the Registrant's report on Form 10-Q for the quarter ended September 30, 2011.
|
d.
|
Incorporated by reference from the Exhibit shown in parentheses filed with the Commission in the Registrant’s report on Form 8-K filed on June 5, 2001.
|
e.
|
Incorporated by reference from the Exhibit shown in parentheses filed with the Commission in the Registrant’s report on Form 8-K filed on February 25, 2003.
|
f.
|
Incorporated by reference from the Exhibit shown in parentheses filed with the Commission in the Registrant’s report on Form 8-K filed on August 11, 2004.
|
g.
|
Incorporated by reference from the Exhibit shown in parentheses filed with the Commission in the Registrant’s report on Form 8-K filed on August 17, 2006.
|
h.
|
Incorporated by reference from the Exhibit shown in parentheses filed with the Commission in the Registrant’s report on Form 8-K filed on September 21, 2009.
|
i.
|
Incorporated by reference from the Exhibit shown in parentheses filed with the Commission in the Registrant’s report on Form 8-K filed on May 31, 2011.
|
*
|
Filed with this report.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|---|---|---|
William Johnson Independent Board Chair Director Since: 2009 Age: 76 Board Committees • Nominating and Corporate Governance (Chair) • Executive Public Board Directorships • Sovos Brands, Inc. (2017-2024) • PepsiCo, Inc . (2015-2020) | |||
Wayne Hewett Independent Director Director Since: 2020 Age: 60 Board Committees • Audit Public Board Directorships • Home Depot, Inc. (since 2014) • Wells Fargo & Company (since 2019) Other Notable Affiliations • Hexion Chemicals (Lead Director since 2023) • Cambrex Corporation (Non- Executive Chairman since 2020) • Lytx, Inc. (Board Member 2021-2025) • Quotient Sciences (Non- Executive Chairman since 2023) • DiversiTech Corporation (Non-Executive Chairman 2018-2021) | |||
Russell Stokes Independent Director Director Since: 2020 Age: 53 Board Committees • Compensation and Human Capital • Nominating and Corporate Governance Other Notable Affiliations • Metro Atlanta Chamber of Commerce Executive Committee • Atlanta Committee for Progress | |||
Rodney Adkins Independent Director Director Since: 2013 Age: 66 Board Committees • Risk (Chair) • Compensation and Human Capital • Executive Public Board Directorships • Avnet, Inc. (since 2015) • PayPal Holdings, Inc. (since 2017) • W.W. Grainger, Inc. (since 2014) | |||
Wayne Hewett Independent Director Director Since: 2020 Age: 60 Board Committees • Audit Public Board Directorships • Home Depot, Inc. (since 2014) • Wells Fargo & Company (since 2019) Other Notable Affiliations • Hexion Chemicals (Lead Director since 2023) • Cambrex Corporation (Non- Executive Chairman since 2020) • Lytx, Inc. (Board Member 2021-2025) • Quotient Sciences (Non- Executive Chairman since 2023) • DiversiTech Corporation (Non-Executive Chairman 2018-2021) | |||
Kevin Clark Independent Director Director Since: 2025 Age: 62 Board Committees • Audit (1) Public Board Directorships • Aptiv (since 2015) | |||
Kevin Clark Independent Director Director Since: 2025 Age: 62 Board Committees • Audit (1) Public Board Directorships • Aptiv (since 2015) | |||
Kate Johnson Independent Director Director Since: 2020 Age: 57 Board Committees • Nominating and Corporate Governance • Risk Public Board Directorships • Lumen Technologies (since 2022) | |||
Franck Moison Independent Director Director Since: 2017 Age: 71 Board Committees • Nominating and Corporate Governance • Risk Public Board Directorships • VusionGroup SA (since 2020) • Hanesbrands Inc. (since 2015) Other Notable Affiliations • SomaLogic, Board Member (2019 - 2021) • EDHEC Business School (Paris, London, Singapore), Chairman of the International Advisory Board • McDonough School of Business, Georgetown University, International Board member | |||
Eva Boratto Independent Director Director Since: 2020 Age: 58 Board Committees • Audit (Chair) | |||
Christiana Smith Shi Independent Director Director Since: 2018 Age: 65 Board Committees • Compensation and Human Capital (Chair) • Risk Public Board Directorships • Columbia Sportswear Company (since 2022) • Williams Sonoma, Inc. (2017-2019) • Mondelez International, Inc. (2016-2023) | |||
Carol B. Tomé Chief Executive Officer and Director Director Since: 2003 Age: 68 Board Committees • Executive Public Board Directorships • Verizon Communications, Inc. (since 2021) • Cisco Systems, Inc. (2019-2020) Other Notable Affiliations • Atlanta Committee for Progress (Chair and Board Member) • Grady Memorial Hospital Corporation (Board Member) • Federal Reserve Bank of Atlanta (Board Member 2008 -2013, Board Chair 2010 - 2012) | |||
Angela Hwang Independent Director Director Since: 2020 Age: 59 Board Committees • Audit Other Notable Affiliations • Connecticut Innovations (Board Member) • Cornell Johnson School of Management Advisory Council |
Name and
Principal Position
|
Year |
Salary
($)
|
Bonus
($)
|
Stock
Awards
($)
|
Option
Awards
($)
|
Non-Equity
Incentive Plan
Compensation
($)
|
Change in
Pension
Value and
Nonqualified
Deferred
Compensation
Earnings
($)
|
All Other
Compensation
($)
|
Total
($)
|
||||||||||||||||||||
Carol Tomé
Chief Executive
Officer
|
2024
|
1,509,713 | — | 18,283,138 | 1,358,768 | 2,747,677 | — | 164,681 | 24,063,977 | ||||||||||||||||||||
2023 | 1,509,713 | — | 18,916,192 | 1,358,762 | 1,509,713 | — | 95,671 | 23,390,051 | |||||||||||||||||||||
2022 | 1,466,250 | — | 15,046,968 | 1,228,547 | 1,035,932 | — | 187,504 | 18,965,201 | |||||||||||||||||||||
Brian Dykes
Chief Financial
Officer
|
2024 | 619,553 | — | 2,500,130 | 103,515 | 758,713 | 0 | 117,856 | 4,099,767 | ||||||||||||||||||||
Brian Newman
Former Chief
Financial Officer
|
2024
|
349,052 | — | 4,708,740 | 418,893 | 438,340 | — | 1,900,756 | 7,815,781 | ||||||||||||||||||||
2023 | 831,626 | — | 5,551,095 | 406,692 | 481,692 | — | 70,965 | 7,342,070 | |||||||||||||||||||||
2022 | 784,377 | — | 5,563,543 | 382,755 | 364,363 | — | 94,203 | 7,189,241 | |||||||||||||||||||||
Nando Cesarone
President U.S. and
UPS Airline
|
2024
|
867,501 | — | 3,901,807 | 424,211 | 914,499 | — | 119,314 | 6,227,332 | ||||||||||||||||||||
2023 | 840,254 | — | 4,686,065 | 407,924 | 487,837 | — | 99,161 | 6,521,241 | |||||||||||||||||||||
2022 | 768,042 | — | 4,348,893 | 351,117 | 364,278 | — | 107,812 | 5,940,142 | |||||||||||||||||||||
Kate Gutmann
President
International,
Healthcare and
Supply Chain
Solutions
|
2024
|
867,501 | — | 3,901,807 | 424,211 | 914,499 | 0 | 148,472 | 6,256,490 | ||||||||||||||||||||
2023 | 840,254 | — | 4,686,065 | 407,924 | 487,837 | 3,786,483 | 152,958 | 10,361,521 | |||||||||||||||||||||
2022 | 781,197 | — | 4,674,444 | 377,426 | 364,278 | — | 20,676 | 6,218,021 | |||||||||||||||||||||
Bala Subramanian
Chief Digital and
Technology Officer
|
2024
|
790,556 | 250,000 | 3,555,753 | 386,601 | 833,385 | — | 79,671 | 5,895,966 | ||||||||||||||||||||
2023 | 766,622 | 500,000 | 4,139,164 | 373,540 | 444,566 | — | 76,370 | 6,300,262 | |||||||||||||||||||||
2022 | 330,853 |
250,000
|
6,928,392 | — | — | — | 932 | 7,510,177 |
Suppliers
Supplier name | Ticker |
---|---|
Tesla, Inc. | TSLA |
General Motors Company | GM |
PACCAR Inc | PCAR |
Fiserv, Inc. | FISV |
Honda Motor Co., Ltd. | HMC |
NVR, Inc. | NVR |
CNH Industrial N.V. | CNHI |
Lennar Corporation | LEN |
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|---|---|---|
Gutmann Kathleen M. | - | 91,090 | 0 |
Gutmann Kathleen M. | - | 73,225 | 0 |
Brothers Norman M. Jr | - | 47,837 | 0 |
WARREN KEVIN M | - | 39,738 | 6,697 |
Lane Laura J | - | 18,717 | 0 |
Subramanian Bala | - | 16,417 | 0 |
Dykes Brian M | - | 13,945 | 0 |
Newman Brian | - | 11,677 | 9,287 |
Subramanian Bala | - | 7,401 | 0 |
Ford Darrell L | - | 6,602 | 0 |
JOHNSON WILLIAM R | - | 5,160 | 0 |
Guffey Matthew W | - | 4,372 | 0 |
Guffey Matthew | - | 944 | 0 |
Cesarone Nando | - | 1 | 0 |